Dangan, Jeralyn G.
HRN: 18-07-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2022
CEFUROXIME 500MG (TAB)
10/17/2022
10/23/2022
ORAL
500mg
BID
S/P NSVD PROM X 14hours
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes